NORTHBROOK, Ill., June 8, 2018 /PRNewswire/ -- Astellas today appointed Nahrin Marino to vice president, head of Ethics & Compliance, Americas effective July 15. Previously, Marino served as deputy general counsel, Regulatory for Astellas. She will direct a team of professionals in Canada, United States and Latin America, and will report to Senior Vice President and Head of Ethics & Compliance Tatjana Dragovic who has responsibility for the global function.
"Nahrin acts with the highest sense of ethics and integrity, which will enable our team to advance our mission of maintaining Astellas' commitment to the highest ethical standards," said Dragovic. "Nahrin is not only an accomplished attorney who has worked closely with Ethics & Compliance over the years, but also is a role model for Astellas serving actively as a professional mentor and community volunteer."
Marino began her career in the pharmaceutical industry as a professional healthcare representative in 1999. Prior to Astellas, she worked at Dykema Gossett, representing corporations in pharmaceutical and medical device litigation. She joined Astellas in 2010 as senior corporate counsel, rising to her current position following several promotions and increasing responsibilities within the company. Marino is an active member of Astellas' Stellar Women Employee Resource Group, whose mission is to create an environment of empowerment and advocacy to advance and inspire women at Astellas. In May 2018, she received the Luminary Award from the Healthcare Businesswomen's Association (HBA). Marino received her undergraduate degree in biology from the Illinois State University and graduated magna cum laude from The John Marshall Law School.
Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. For more information on Astellas, please visit our website at www.astellas.us. You can also follow us on Twitter at @AstellasUS, Facebook at www.facebook.com/AstellasUS or LinkedIn at www.linkedin.com/company/astellas-pharma.
SOURCE Astellas Pharma US, Inc.
For further information: Erin Green, 847-612-4413, [email protected]